Leadership

Executive Team

Ron Lattanze
CEO
• 26 years in healthcare
• Former member of Guidant Management Committee
• Former President Guidant Endovascular Solutions
• Former President Guidant Japan and Managing Director Guidant Asia
• Served as an Officer in the US Navy
• BS and MBA, University of North Carolina, Chapel Hill
Steve Perrin
VP Software
• 30 years in software development networking/communications and signal processing
• 55 issued patents, multiple “most valuable patent” awards
• BSEE from North Carolina State University and MSEE from Georgia Institute of Technology
• 10 years senior researcher, Lenovo and 17 years senior engineer, IBM
• “Inventor of the Year” recognition at Lenovo
Josh Knowland
VP Product Development, Co-Founder
• 16 years in electrical systems engineering and technology development
• Experience in manufacturing, telecommunications, and medical devices
• 12 years in medical devices including implantable dosimetry devices and radiation measurement
• BSEE and BSCPE from North Carolina State University
Bill Gorge
CFO
• 25 years in medical device industry
• Former Managing Director Guidant, Australia & New Zealand
• Former VP of Finance and VP of Human Resources Guidant U.S. Sales
• BS in engineering and MBA, Northwestern University

Board of Directors

Ron Lattanze
Board Member
Ron specializes in recruiting highly talented teams and brings operations, international, and executive management experience to Lucerno. Ron was a member of Guidant Corporation’s Management Committee. He served as President, Guidant Endovascular Solutions. Before running Endovascular Solutions, Ron lived in Tokyo for over four years and served as President, Guidant Japan. Before moving to Tokyo, Ron lived in Hong Kong for three years as the Managing Director for Guidant’s Asia Operations. He received both a BA and MBA from the University of North Carolina at Chapel Hill. Between earning degrees, he served as an officer in the US Navy.
Anne M. Smalling
Board Member
Anne M. Smalling is President and Managing Partner of HM International, LLC (HMI). Anne serves as the Chair of the Boards of Directors of Quality Sausage Company and American Innovations and also serves on the Boards of Igasamex, Lucerno, Garrison Brothers and rateGenius, Inc. Anne is on the advisory boards of Tiff’s Treats, Access Venture Partners and 2X Partners. She formerly served on the Boards of Directors of Ninthhouse, PDI-Ninth House and Quick Arrow. Anne is a member of the Cornell University Board of Trustees and a member of Board of Directors and Executive Committee of Ronald McDonald Charities of Central Texas. Prior to her positions with HMI Anne worked for FMC Corporation and SmithKline Beecham. Anne has a BS in Developmental Psychology from Cornell University and MBA from Harvard Business School.
Brad Wilson
Board Member
Brad served almost 8 years as CEO of BlueCross BlueShield of NC during which time the company successfully implemented the ACA and enjoyed strong customer and financial growth. He also served as COO and General Counsel during a 22-year career at BCBSNC. Before joining Blue Cross NC, he served as General Counsel to N.C. Governor James B. Hunt from 1992 to 1995 and was a practicing attorney from 1978 to 1992. Brad served 16 years on the UNC Board of Governors and Chaired the Board for 4 years. Has served on or Chaired a number of Gubernatorial Commissions on a variety of topics. He is recipient of the Order of the Long Leaf Pine, the highest NC civilian honor. Brad received a BA from Appalachian State University, Juris Doctorate from Wake Forest University School of Law, and MA from Duke University.
Don Kiepert
Board Member
Don has been a successful entrepreneur who has started and led twelve healthcare companies. He has chaired and served on multiple healthcare company boards and advised leading PE firms on various acquisition opportunities. Don started Chartwell Home Therapies, a national home infusion services company. In 2014 and 2015 he spent fifteen months as a full-time advisor to Bain Capital. Don served as a board member and CEO of Lantheus Medical Imaging. Prior to Lantheus, he founded Point Therapeutics, which went public and raised $100M in capital. Don recently founded Seropeutics, LLC an early stage biopharmaceutical company. Early in Don’s career he held multiple senior manager positions at Baxter Travenol, including co-founding the Travacare Division. Current board roles include Curium Pharma and Lucerno. He also serves as a board advisor to Reiley Pharmaceuticals, Terran Biosciences, Bach Biosciences, and ImmunoTrace, LLC. Don received both BS and MS in Pharmacy from Purdue University.
Brian Goldstein, MD
Board Member
Brian Goldstein is a Clinical Professor at University of North Carolina at Chapel Hill School of Medicine. He has twenty-five years of experience as a physician-executive, with a consistent focus on innovations that enhance health care for patients and consumers and improve physicians’ practice. Brian served as a Chief Operating Officer at Seattle-based University of Washington Medicine from 2016 to 2018. He served as UNC Hospitals’ Executive Vice President and Chief Operating Officer from 2010 to 2016. Prior to that appointment, he served for eight years as UNC Hospitals’ Chief of Staff and as the UNC School of Medicine’s Executive Associate Dean for Clinical Affairs. Brian received his medical degree from NYU School of Medicine.

Advisers

Marjan Boerma, PhD
Radiation Biology Adviser
Marjan is a radiation biologist with a research expertise in normal tissue radiation injuries. She received her MS in cellular biology and PhD in radiation biology in the Netherlands. She has been on the faculty at the University of Arkansas for Medical Sciences (UAMS) since 2006 and is currently the director of the UAMS Division of Radiation Health and the COBRE Center for Studies of Host Response to Cancer Therapy. Her research is focused on pre-clinical models to study cardiovascular effects of ionizing radiation and is funded by NIH, DoD and NASA.
David Townsend, PhD
Scientific Adviser
David is considered a leading authority on hybrid imaging systems. He is a co-inventor of the PET/CT scanner and one of the pioneers of three-dimensional PET and its required reconstruction algorithms. An IEEE Fellow, he served as director of the A*STAR-NUS Clinical Imaging Research Centre in Singapore and Professor of Radiology, National University of Singapore from 2009 to June 2018. David received the Paul C. Aebersold Award for Outstanding Achievement in Basic Nuclear Medicine Science in 2015.
P. David Mozley, MD
Clinical Adviser
P. David, Professor of Radiology at Weill Cornell in Manhattan, has a unique industry/academia background. He has served as VP of Imaging at Endocyte, Senior Director of Imaging at Merck, and a Medical Fellow at Eli Lilly. He has also served as Professor and Chief of Nuclear Medicine at Weill Cornell Medical College and Associate Professor of Radiology at the University of Pennsylvania. Dr. Mozley has contributed to over 100 peer-reviewed publications on imaging, serves on the Steering Committee for the Quantitative Imaging Biomarker Alliance sponsored by RSNA, and is a former chair of the PhRMA Imaging group.
Charles Scarantino, MD PhD
Adviser, Co-Founder
Chuck is a retired radiation oncologist from UNC Healthcare and a seasoned entrepreneur. It was his frustration with existing tools for assessing therapy response that led to Lucerno’s founding. Chuck was granted his medical degree from the Bowman Gray School of Medicine at Wake Forest University after completing his PhD in cell physiology at St. John’s University.
Peyton Anderson
Business Adviser
CEO, Affinergy
John Cambier
Business Adviser
Managing Partner at IDEA Fund Partners
Joe Colarusso
Business Adviser
President, JVC Consulting
Michael Gropp
Business Adviser
Former Medical Technology International Regulatory Policy Executive
Fred McCoy
Business Adviser
CEO, NeuroTronik; Vice Chairman and Co-Founder of Synecor
Keisuke Suzuki
Business Adviser
Principal, Keisuke Med Tech Consulting
Rob Van Arnam
Business Adviser
Partner, Williams Mullen; Co-Chair, Intellectual Property